Butterfly Network, Inc. (“Butterfly”) (NYSE:BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, today announced that Fierce Life Sciences and Fierce Healthcare have named Butterfly as one of 2024’s Fierce 50 honorees. The Fierce 50 showcases 50 individuals and companies driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909393991/en/

Butterfly Network named a 2024 Fierce 50 Honoree. (Graphic: Business Wire)

Butterfly’s inclusion in the Fierce 50 is a reflection of the exceptional progress the Company has made this year. The successful launch of the next-generation Butterfly iQ3™ has solidified Butterfly’s leadership in revolutionizing the ultrasound industry. The Company has also established itself as a key catalyst for ultrasound artificial intelligence (AI) innovation through its Butterfly Garden™ program, creating an ecosystem for developers to bring the best AI tools to Butterfly’s expansive physician network. Simultaneously, Butterfly has ensured the benefits of its proprietary Ultrasound-on-Chip™ will reach well-beyond its core ultrasound market by creating a chip-licensing program that enables partners to develop novel technologies that are Powered by Butterfly™.

“Being named to the Fierce 50 is a testament to our team’s relentless pursuit of innovation and excellence,” said Joseph DeVivo, President, Chief Executive Officer, and Board Chairman of Butterfly Network. “As a mission-driven company, we are honored to be recognized for our leadership in democratizing medical imaging by advancing access, affordability and sustainability with our chip-based, environmentally-conscious solution. We are proud to be driving a digital revolution for the ultrasound industry at large, and pushing toward a future where practitioners everywhere use digital ultrasound to practice faster, better medicine for patients worldwide.”

“The annual Fierce 50 special report highlights individuals and companies that are driving progress in the pharmaceutical, healthcare and biotechnology industries,” said Ayla Ellison, Editor-in-Chief of Fierce Life Sciences and Healthcare. “These 50 outstanding organizations and people demonstrate excellence in their fields, and their commitment to innovation, equity and improving lives is truly commendable. Congratulations to this year’s honorees.”

The Fierce 50 is a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Biotech, Fierce Pharma and Fierce Healthcare. These individuals and companies are a driving force in healthcare delivery, drug development, research, and more.

To read the Butterfly feature article in the 2024 Fierce 50 report, visit https://www.fiercepharma.com/pharma/butterfly-network. To learn more about Butterfly, visit: https://www.butterflynetwork.com/

About Butterfly Network

Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network is a digital health company with a mission is to democratize medical imaging by making high-quality ultrasound affordable, easy-to-use, globally accessible, and intelligently connected, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly created the world's first handheld single-probe, whole-body ultrasound system using semiconductor technology, Butterfly iQ. The company has continued to innovate, leveraging the benefits of Moore’s Law, to launch its second generation Butterfly iQ+ in 2020, and third generation iQ3 in 2024 – each with increased processing power and performance enhancements. The disruptive technology has been recognized by TIME’s Best Inventions, Fast Company’s World Changing Ideas, CNBC Disruptor 50, and MedTech Breakthrough Awards, among other accolades. With its proprietary Ultrasound-on-Chip™ technology, intelligent software, and educational offerings, Butterfly is paving the way to mass adoption of ultrasound for earlier detection and remote management of health conditions around the world. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: www.butterflynetwork.com/choose-your-country.

About Questex

Questex helps people live better and longer. Questex brings people together in the markets that help people live better: travel, hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy – connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.

The Fierce 50 honorees will be celebrated live at an evening gala at the Lighthouse at Pier Sixty One in New York on December 5th. For more information visit https://fierce50.fiercelifesciences.com/.

Questex Media: Linda Lam Director of Marketing, Life Sciences and Healthcare llam@questex.com

Butterfly Media: Liz Learned Head of Corporate Communications, Butterfly media@butterflynetwork.com

Butterfly Investors: Heather Getz Chief Financial and Operations Officers, Butterfly investors@butterflynetwork.com

Butterfly Network (NYSE:BFLY)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Butterfly Network Charts.
Butterfly Network (NYSE:BFLY)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Butterfly Network Charts.